An "-omycs" Toolbox to Work with MYC
Jonathan Whitfield1, Laura Soucek2,3,4,5
1Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. jwhitfield@vhio.net.
Abstract:
The MYC transcription factor coordinates a wide range of intra- and extracellular processes associated with tissue proliferation and regeneration. While these processes are typically tightly regulated in physiological conditions, they become deregulated in cancer, where MYC is oncogenically activated.The last decade has seen MYC progress from a renowned undruggable target to a hot topic in the cancer therapy field, as proof emerged from mouse models that its inhibition constitutes an effective and broadly applicable approach to fight cancer. However, there are several aspects of MYC biology that still appear to be elusive and maintain the interest in further studying this intriguing protein. Since MYC's discovery, more than four decades ago, multiple strategies have been developed to study it, related to the many and varied facets of its biology. This new version of The Myc gene: Methods and Protocols provides valuable tips from key "inhabitants of the MYC world," which significantly increase the reach of our investigative tools to shed light on the mysteries still surrounding MYC.
Insights
MYC, a key regulator of cell growth, becomes oncogenic in cancer. New research highlights MYC inhibition as a promising cancer therapy, offering novel methods to study this complex protein.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The MYC transcription factor regulates cell proliferation and regeneration.
- MYC dysregulation is a hallmark of many cancers.
- MYC has emerged as a viable, albeit challenging, cancer therapeutic target.
Discussion:
- MYC's role in cancer necessitates a deeper understanding of its complex biology.
- Developing effective MYC-targeting therapies remains a significant challenge.
- Recent advancements in MYC research offer new avenues for therapeutic intervention.
Key Insights:
- MYC inhibition shows promise as a broad-spectrum cancer treatment strategy.
- Mouse models demonstrate the efficacy of targeting MYC in cancer.
- Understanding MYC's multifaceted roles is crucial for advancing cancer therapy.
Outlook:
- Continued investigation into MYC biology is essential for refining cancer treatments.
- New methodologies are expanding our ability to study MYC.
- The development of novel MYC-targeting drugs is an active area of research.
